Skip to content
The Mumbai

Laurus Labs Invests ₹107.8 Crore In KRKA Pharma, Maintains 49% Stake

Laurus Labs Invests ₹107.8 Crore In KRKA Pharma, Maintains 49% Stake
Photo: Free Press Journal · view original

Mumbai: Laurus Labs Limited has invested ₹107.8 crore in KRKA Pharma Private Limited through a rights issue, according to a company announcement dated October 14, 2026. The pharmaceutical company acquired 10.78 crore equity shares with a face value of ₹10 each. The investment follows an earlier i...

Sources and story details